evaluating response to treatment in patients with emd
Published 1 year ago • 71 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
3:17
estimating transfusion-related medical costs & time burden in patients with mf in simplify-1
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
1:05
the importance of using mrd to guide treatment decisions in all
-
1:42
applying next-generation sequencing in the diagnosis of rare inherited anemias
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
1:16
insights into an oncology simulation model being used to evaluate treatment regimens in hl
-
5:26
evaluating responses to immunotherapies with non-invasive tools
-
1:17
phase ii study of tosedostat in mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml